Veracity Capital LLC Blueprint Medicines Corp Transaction History

Veracity Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$54.1 - $110.08 $276,667 - $562,949	-5,114 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$94.25 - $115.99 $94,250 - $115,990	-1,000 Reduced 16.36%	5,114 $548,000
Q2 2021 Jul 22, 2021	BUY	$82.78 - $101.0 $496 - $606	6 Added 0.1%	6,114 $538,000
Q4 2020 Jan 25, 2021	SELL	$92.08 - $124.48 $368,320 - $497,920	-4,000 Reduced 39.57%	6,108 $685,000
Q2 2020 Jul 13, 2020	SELL	$57.09 - $79.27 $576,266 - $800,151	-10,094 Reduced 49.97%	10,108 $788,000
Q4 2019 May 07, 2020	BUY	$66.73 - $82.59 $1.35 Million - $1.67 Million	20,202 New	20,202 $1.62 Million

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.38B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Veracity Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Veracity Capital LLC with notifications on news.